High‐grade squamous intraepithelial lesions and adenocarcinoma in situ with a negative HPV cervical screening test. The role of HPV ‐ ISH testing: A retrospective review
Australian and New Zealand Journal of Obstetrics and Gynaecology · 2025
DOI: 10.1111/ajo.13892 ↗Kurz gefasst
Fachartikel in der Zeitschrift Australian and New Zealand Journal of Obstetrics and Gynaecology, 2025. Verfasst von Jonathan Sandeford und 4 weiteren Autor:innen. Beteiligte Einrichtung: Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia. Hauptthemen laut MEDLINE: Uterine Cervical Neoplasms, Adenocarcinoma in Situ, Papillomavirus Infections, Squamous Intraepithelial Lesions of the Cervix. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 18 Literaturangaben. Gefördert von: ASCCP.
Abstract (Originalsprache)
Australia has transitioned to primary Human Papillomavirus (HPV) screening; however, high‐risk HPV (hrHPV)‐negative high‐grade squamous intraepithelial lesions and adenocarcinoma in situ have been reported. HPV in situ hybridisation (ISH) testing has been proposed to reclassify these cases. This study identified hrHPV‐negative lesions and assessed HPV‐ISH. A total of 89 of 1468 patients (6.06%) had hrHPV‐negative lesions, and HPV‐ISH revealed five (5.75%) reclassified positive cases. No demographical differences were found between groups. Current population‐level screening is effective. HPV‐ISH was not effective for reclassification. This small, significant population requires further study to assess the phenomenon and augment detection given the implications of misidentification.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia.
- Department of Gynaecological Oncology, The Chris O'Brien Lifehouse, Sydney, New South Wales, Australia.
- Department of Gynaecological Oncology, Westmead Hospital, Sydney, New South Wales, Australia.
- Department of Pathology, Royal Prince Alfred Hospital, Sydney, New South Wales, Australia.
ORCID-Profile: Jonathan Sandeford
Förderung
- ASCCP
Zitieren
APA
Sandeford, J., Herbst, U., Lum, T., Anderson, L., & Pather, S. (2025). High‐grade squamous intraepithelial lesions and adenocarcinoma in situ with a negative HPV cervical screening test. The role of HPV ‐ ISH testing: A retrospective review. Australian and New Zealand Journal of Obstetrics and Gynaecology. https://doi.org/10.1111/ajo.13892
Vancouver
Sandeford J, Herbst U, Lum T, Anderson L, Pather S. High‐grade squamous intraepithelial lesions and adenocarcinoma in situ with a negative HPV cervical screening test. The role of HPV ‐ ISH testing: A retrospective review. Australian and New Zealand Journal of Obstetrics and Gynaecology. 2025. doi:10.1111/ajo.13892
BibTeX
@article{Sandeford2025,
author = {Sandeford, Jonathan and Herbst, Unine and Lum, Trina and Anderson, Lyndal and Pather, Selvan},
title = {High‐grade squamous intraepithelial lesions and adenocarcinoma in situ with a negative HPV cervical screening test. The role of HPV ‐ ISH testing: A retrospective review},
journal = {Australian and New Zealand Journal of Obstetrics and Gynaecology},
year = {2025},
doi = {10.1111/ajo.13892}
}
EUVIMED